Gedii

2019

2018

Bolsas de Doutoramento 2018/19

Projecto: Azathioprine and metabolites - pharmacokinetic and inflammatory implications

Bolsas de Investigação 2018/19

Projectos premiados:

"Targeting miR-21 in PSC-IBD patients" - André Santos
"Pharmacological interventions upon ion sensing and transport mechanisms in fibrotic Crohn's disease" - Dina Cosme

2017

Bolsas de Investigação 2017/18

Projecto premiado:

"Azathioprine and metabolites - pharmacokinetic and inflammatory implications" - Paula Cristina Ribeiro Fernandes de Sousa

2016

Bolsas de Investigação 2016/17

Projectos premiados:

"DEVELOPMENT OF A HISTOPATHOLOGICAL SCORE TO MESURE AND DECIPT INTESTINAL WALL INFLAMMATION AND FIBROSIS IN CD OF THE ILEUM - DIFICIL STUDY" - Helena Tavares de Sousa
“PROSPECTIVE COHORT OF NEWLY DIAGNOSED CROHN'S DISEASE - Crohn's disease Observational Cohort Study" - Joana Torres
“SWEET: GLYCANS AS NOVEL IMMUNOMODULATORS IN IBD” - Salomé Pinho
“THE ROLE OF T LYMPHOCYTE DIFFERENTIATION IN IBD - ASSOCIATED COLORECTAL CARCINOMA” - José Carlos Machado

2015

Bolsas de investigação 2015/16

Projectos premiados:

"Role for the renin-angiotensin system in inflammatory bowel disease: mechanisms and translation" - MANUELA MORATO
"Avaliação da expressão de glucagon-like peptide 2 and dipeptidil peptidase 4 em biópsias intestinais de doentes com DII versus controlos e em dois modelos celulares de inflamação intestinal"- PEDRO LOPES
"Setting the basis for exploring the co-participation of adherent-invasive Escherichia coli and Mycobacterium avium subsp. paratuberculosis in Crohn's disease" – AMELIA ASSUNÇAO
Alterações da coagulação numa população de doentes com doença inflamatória intestinal; Coagulation disorders in a population of patients with inflammatory bowel disease" – JULIANA PINHO

2014

Bolsas de investigação 2014/15

Projectos premiados:

Primary human monocyte culture as in vitro model of IFX pharmacokinetics: Influence of immunogenicity, immunosuppressive agents, albumin and inflammation. - Joana Afonso
The role of gut microbiome, diet, and bile acid metabolism in IBD and in special IBD populations - exploring interactions that may predispose to special phenotypes. - Joana Torres
The role of biliary salts malabsorption in inflammatory bowel disease: relationship with butyrate. - Mafalda Couto
Genetics variations in FCGR3 receptors: implications in Infliximab therapeutics in inflammatory bowel disease. - Paula Serrão
MGAT5 as a potential new gene determining severity in Inflammatory Bowel Disease. - Salomé Pinho
Mesenchymal stem cells in inflamatory bowel disease: therapeutic strategy or cancer promoters? - Sergia Velho

2013

Bolsas 2013/14

Projectos premiados:

Perturbation of the intestinal barrier function in Inflammatory Bowel Diseases: role of the Rac1b /cytokine axis – PETER JORDAN
Silent Myocardial Ischemia in Inflammatory Bowel Disease – TIAGO VIEIRA
Oxidative Stress and DNA damage in Portuguese IBD patients – CRISTIANA COSTA PEREIRA
O papel do glucagon-like peptide 2 e da dipeptidil peptidase 4/CD26 na Doença de Crohn – PEDRO LOPES
Lack of response of infliximab in pediatric IBD patient – MARTA TAVARES
Screening and monitoring of Epstein-Barr viremia in Patients with Inflammatory Bowel Diseases (IBD) under therapy (5-ASA, azathioprin, infliximab and infliximab plus azathioprin) and in healthy controls – CANDIDA ABREU

2012

Bolsa de Investigação GEDII 2012/13

Agenda

De 04 de abril a 06 de abril de 2024

Reunião Anual 2024

Desenvolvido por DogmaSis